Physician profile
Joseph A Beals
NPI 1164512323
$791.34
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $194 · 2021: $139 · 2022: $49.05.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $187.31 | 2019-2022 | |
| Abbvie INC. | $126.31 | 2019-2021 | |
| Amgen INC. | $114.13 | 2019 | |
| Exeltis, USA INC. | $82.02 | 2019-2022 | |
| Therapeuticsmd, INC. | $70.41 | 2019-2021 | |
| Mission Pharmacal Company | $32.94 | 2019-2020 | |
| Myovant Sciences INC. | $24.68 | 2021 | |
| Novo Nordisk INC | $24.25 | 2019 | |
| Coopersurgical, INC. | $20.41 | 2020 | |
| Amag Pharmaceuticals, INC. | $19.34 | 2019 | |
| Bausch Health US, LLC | $17.85 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.16 | 2019 | |
| Scynexis, INC. | $15.80 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.68 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.99 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $12.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Beals listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.